Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.23.3
CONSOLIDATED BALANCE SHEETS - USD ($)
Aug. 31, 2023
Aug. 31, 2022
Current    
Cash $ 1,352,102 $ 5,813,218
Marketable securities 125,642 347,335
Accounts receivable 175,245 201,784
Inventory 0 38,418
Prepaid expenses and other current assets 546,783 576,761
Total Current Assets 2,199,772 6,977,516
Non-current assets, net    
Right of use assets 167,446 52,444
Intellectual property, net 462,625 488,462
Property & equipment, net 254,143 315,505
Total Non-current Assets 884,214 856,411
TOTAL ASSETS 3,083,986 7,833,927
Current Liabilities    
Accounts payable and accrued liabilities 239,941 151,449
Lease liability, current 27,794 42,587
Total Current Liabilities 267,735 194,036
Lease liabilities - non-current 136,173 7,401
TOTAL LIABILITIES 403,908 201,437
Share Capital    
Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 8,091,650 and 5,950,998 at August 31, 2023 and August 31, 2022, respectively 8,091 5,951
Additional paid-in capital 48,799,454 47,041,481
Accumulated deficit (45,763,427) (39,098,528)
Equity attributable to shareholders of Lexaria 3,044,118 7,948,904
Non-controlling Interest (364,040) (316,414)
Total Stockholders' Equity 2,680,078 7,632,490
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,083,986 $ 7,833,927